| John D Mccallum Iii, MD | |
|
2408 Whitney Ave, Hamden, CT 06518-3209 | |
| (203) 407-3545 | |
| (203) 466-8591 |
| Full Name | John D Mccallum Iii |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 35 Years |
| Location | 2408 Whitney Ave, Hamden, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447247606 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 34635 (Connecticut) | Secondary |
| 207X00000X | Orthopaedic Surgery | 34635 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midstate Medical Center | Meriden, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Orthopaedic Specialists Pc | 7315850039 | 154 |
News Archive
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADAR, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.
› Verified 3 days ago
| Entity Name | Connecticut Orthopaedic Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235181389 PECOS PAC ID: 7315850039 Enrollment ID: O20031110000220 |
News Archive
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADAR, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.
› Verified 3 days ago
| Entity Name | Midstate Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154425288 PECOS PAC ID: 7416840699 Enrollment ID: O20040203000244 |
News Archive
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADAR, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John D Mccallum Iii, MD 2408 Whitney Ave, Hamden, CT 06518-3209 Ph: (203) 626-0160 | John D Mccallum Iii, MD 2408 Whitney Ave, Hamden, CT 06518-3209 Ph: (203) 407-3545 |
News Archive
End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.
VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.
According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of taste or smell, or other health issues long after they test negative for the virus. It can be defined as having serious and prolonged symptoms three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADAR, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.
› Verified 3 days ago
Dr. Nicola Shamsey Corbett, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Washington Ave Fl 1-a, Hamden, CT 06518 Phone: 203-865-6784 Fax: 203-865-6788 | |
Dr. Louis Iorio, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9 Washington Ave, Hamden, CT 06518 Phone: 203-865-6784 Fax: 203-865-6788 | |
Dr. Shirvinda A Wijesekera, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Washington Ave Fl 1a, Hamden, CT 06518 Phone: 203-865-6784 Fax: 203-865-6788 | |
Dr. Rowland B Mayor, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2416 Whitney Ave Ste 3, Hamden, CT 06518 Phone: 203-752-3100 Fax: 203-752-9291 | |
Dr. John F Irving, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9 Washington Ave Fl 1-a, Hamden, CT 06518 Phone: 203-865-6784 Fax: 203-865-6788 | |
Mark W Scanlan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2408 Whitney Ave, Hamden, CT 06518 Phone: 203-407-3539 Fax: 203-287-7316 | |
Dr. Glenn Scott Russo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2408 Whitney Ave, Hamden, CT 06518 Phone: 203-407-3508 Fax: 203-672-0842 |